Among them, radiolabeled small molecules/peptides including 68Ga/177Lu/225Ac-PSMA-617, 68Ga/177Lu/225Ac-PSMA-I&T, 68Ga-PSMA-11, 99mTc-MIP-1404, 99mTc-PSMA-I&S, 18F-DCFPyL, Al18F-PSMA-BCH, and 18F-PSMA-1007 currently dominate in clinical trials for PCa imaging or PSMA radioligand therapy (PRLT) [3,4,5,6,7,8,9,10,11,12]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.